Becton, Dickinson and Company (BDX)

Last Price:  

Company Description

Becton, Dickinson & Company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $17.29B
Net Income (Most Recent Fiscal Year) $1.23B
PE Ratio (Current Year Earnings Estimate) 23.41
PE Ratio (Trailing 12 Months) 21.65
PEG Ratio (Long Term Growth Estimate) 2.95
Price to Sales Ratio (Trailing 12 Months) 3.97
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 2.80
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 11.16
Pre-Tax Margin (Trailing 12 Months) 4.97%
Net Margin (Trailing 12 Months) 5.30%
Return on Equity (Trailing 12 Months) 14.19%
Return on Assets (Trailing 12 Months) 5.86%
Current Ratio (Most Recent Fiscal Quarter) 1.45
Quick Ratio (Most Recent Fiscal Quarter) 0.97
Debt to Common Equity (Most Recent Fiscal Quarter) 0.71
Inventory Turnover (Trailing 12 Months) 3.35
Book Value per Share (Most Recent Fiscal Quarter) $78.08
Earnings per Share (Most Recent Fiscal Quarter) $2.20
Earnings per Share (Most Recent Fiscal Year) $11.68
Diluted Earnings per Share (Trailing 12 Months) $2.78
Stock
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Common Shares Outstanding 289.87M
Free Float 289.52M
Market Capitalization $67.22B
Average Volume (Last 20 Days) 1.77M
Beta (Past 60 Months) 0.85
Percentage Held By Insiders (Latest Annual Proxy Report) 0.12%
Percentage Held By Institutions (Latest 13F Reports) 84.18%
Annual Dividend (Based on Last Quarter) $3.16
Dividend Yield (Based on Last Quarter) 1.36%